Lidocaine Hydrochloride
LIDOCAINE HYDROCHLORIDE
Indications and usage 1 INDICATIONS AND USAGE Lidocaine hydrochloride injection is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental, and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.
Specific concentrations and presentations of lidocaine hydrochloride injection is recommended for each type of block indicated to produce local or regional or anesthesia or analgesia [see Dosage and Administration ( 2.2 )].
Structured Monograph
Clinical summary
Indications and usage 1 INDICATIONS AND USAGE Lidocaine hydrochloride injection is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental, and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of lidocaine hydrochloride injection is recommended for each type of block indicated to produce local or regional or anesthesia or analgesia [see Dosage and Administration ( 2.2 )]. Lidocaine hydrochloride injection contains lidocaine, an amide local anesthetic. Lidocaine hydrochloride injection is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental, and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. For each type of block indicated to produce local or regional anesthesia or analgesia, specific concentrations and presentations are recommended. ( 1 , 2.2 ) Dosage and administration 2 DOSAGE AND ADMINISTRATION See Full Prescribing Information for recommended dosages and administration information for adult and pediatric patients 2.1 Important Dosage and Administration Information Lidocaine hydrochloride injection is not recommended for intrathecal use. Avoid use of lidocaine hydrochloride injection solutions containing antimicrobial preservatives (i.e., multiple-dose vials) for epidural or caudal anesthesia [see Warnings and Precautions ( 5.3 )]. Discard unused portions of solution not containing preservatives, i.e., those supplied in single-dose vials, following initial use. Visually inspect this product for particulate matter and discoloration prior to administration whenever solution and container permit. Lidocaine hydrochloride injection is a clear, colorless solutions. Do not administer solutions which are discolored or contain particulate matter. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever the solution and container permit. Solutions which are discolored (e.g., pinkish or darker than slightly yellow) or which contain particulate matter or precipitate should not be administered. Mixing or the prior or intercurrent use of any other local anesthetic with Lidocaine hydrochloride injection is not recommended because of insufficient data on the clinical use of such mixtures. Administration Precautions Lidocaine hydrochloride injection is to be administered in carefully adjusted dosages by or under the supervision of experienced clinicians who are well versed in the diagnosis and management of dose-related toxicity and other acute emergencies which might arise from the block to be employed. Use lidocaine hydrochloride injection only if the following are immediately available: oxygen, cardiopulmonary resuscitative equipment and drugs, and the personnel resources needed for proper management of toxic reactions and related emergencies [see Warnings and Precautions ( 5.1 ), Adverse Reactions ( 6 ), Overdosage ( 10 )]. The toxic effects of local anesthetics are additive. Monitor for neurologic and cardiovascular effects related to local anesthetic systemic toxicity when additional local anesthetics are administered with lidocaine hydrochloride injection [see Warnings and Precautions ( 5.1 ), Drug Interactions ( 7.1 ), Overdosage ( 10 )]. Aspirate for blood or cerebrospinal fluid (where applicable) prior to injecting lidocaine hydrochloride injection, both the initial dose and all subsequent doses, to avoid intravascular or intrathecal injection. However, a negative aspiration for blood or cerebrospinal fluid does not ensure against an intravascular or intrathecal injection [see Warnings and Precautions ( 5.7 )]. Avoid rapid injection of a large volume of lidocaine hydrochloride injection and use fractional (incremental) doses when feasible. During major regional nerve blocks, such as those of the brachial plexus or lower extremity, the patient should have an indwelling intravenous catheter to assure adequate intravenous access. The lowest dosage of lidocaine hydrochloride injection that results in effective anesthesia should be used to avoid high plasma levels and serious adverse reactions. Perform careful and constant monitoring of cardiovascular and respiratory (adequacy of oxygenation and ventilation) vital signs and the patient’s level of consciousness after each local anesthetic injection. Use lidocaine hydrochloride injection in carefully restricted quantities in areas of the body supplied by end arteries or having otherwise compromised blood supply such as digits, nose, external ear, or penis. 2.2 Recommended Concentrations and Dosages of lidocaine hydrochloride injection in Adults The dosage of lidocaine hydrochloride injection administered varies with the anesthetic procedure, the area to be anesthetized, the vascularity of the tissues, the number of neuron
Monitoring
- • 5 WARNINGS AND PRECAUTIONS Dose-Related Toxicity : Monitor cardiovascular and respiratory vital signs and patient’s state of consciousness after injection of lidocaine hydrochloride injection ( 5.1 ) Methemoglobinemia : Cases of methemoglobinemia have been reported in association with local anesthetics use.
- • See full prescribing information for more details on managing these risks.
- • ( 5.2 ) Chondrolysis with Intra-Articular Infusion: Avoid Intra-articular infusions as there have been post-marketing reports of chondrolysis in patients receiving such infusion.
- • ( 5.4 ) Allergic-Type Reactions to Sulfites in Lidocaine Hydrochloride Injection and Anaphylactic Reactions: Lidocaine hydrochloride injection without epinephrine does not contain sodium metabisulfite ( 5.6 ) Risk of Systemic Toxicities with Unintended Intravascular or Intrathecal Injection : Unintended intravascular or intrathecal injection may be associated with systemic toxicities, including CNS or cardiorespiratory depression and coma, progression ultimately to respiratory arrest.
Interaction Notes
- • 7 DRUG INTERACTIONS Local Anesthetics : The toxic effects of local anesthetics are additive.
- • Monitor for neurologic and cardiovascular effects when additional local anesthetics are administered ( 7.1 ) Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : Administration of lidocaine hydrochloride injection to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension Concurrent use of these agents should generally be avoided ( 5.5 , 7.2 ) Ergot-type Oxytocic drugs : Concurrent administration of lidocaine hydrochloride injection and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents ( 5.5 , 7.3 ) Nonselective Beta-Adrenergic Antagonists: Administration of lidocaine hydrochloride injection in patients receiving nonselective beta-adrenergic antagonist may cause severe hypertension and bradycardia.
- • Concurrent use of these agents should generally be avoided.
- • ( 5.5 , 7.4 ) Drugs Associated with Methemoglobinemia : Patients are at increased risk of developing methemoglobinemia when concurrently exposed to nitrates, nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants and other drugs ( 7.5 ).